Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

CJC-1295 Side Effects, Complications, and Risk Profile

Researchers curious about CJC-1295 side effects will find clarity regarding the peptides' safety profile below. While being one of the most popular growth hormone secretagogues, many researchers still lack clarity on the side effects and safety profile of CJC-

Researchers curious about CJC-1295 side effects will find clarity regarding the peptides' safety profile below.

While being one of the most popular growth hormone secretagogues, many researchers still lack clarity on the side effects and safety profile of CJC-1295. With over two decades of research, the peptide still confuses even the most astute researchers from time to time.

This is to be expected, as there are many different versions of the research peptide on the market:

CJC-1295 DAC

CJC-1295 No DAC

CJC-1295 + Ipamorelin

To that end, we summarize the main research findings regarding CJC-1295 side effects, and outline what researchers must know when investigating this growth hormone-releasing hormone analog.

For researchers unfamiliar with CJC-1295, we will also discuss its main benefits such as its effects on sleep, muscle mass, and fat loss.

Buy CJC-1295 No DAC from our top-rated vendor...

Disclaimer: Peptides.org contains information about products that are intended for laboratory and research use only, unless otherwise explicitly stated. This information, including any referenced scientific or clinical research, is made available for educational purposes only. Likewise, any published information relative to the dosing and administration of reference materials is made available strictly for reference and shall not be construed to encourage the self-administration or any human use of said reference materials. Peptides.org makes every effort to ensure that any information it shares complies with national and international standards for clinical trial information and is committed to the timely disclosure of the design and results of all interventional clinical studies for innovative treatments publicly available or that may be made available. However, research is not considered conclusive. Peptides.org makes no claims that any products referenced can cure, treat or prevent any conditions, including any conditions referenced on its website or in print materials.

What is CJC-1295?

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) and growth hormone secretagogue (GHS) that was developed in the early 2000s by Canadian biotech firm ConjuChem Technologies [1].

It has been investigated as a treatment for growth hormone deficiency and lipodystrophy, reaching phase II clinical trials that were discontinued for reasons unrelated to administration of the peptide. Subsequent research has shown that CJC-1295 may enhance sleep, increase muscle mass, and stimulate fat loss in test subjects [1].

CJC-1295 has been marketed with and without drug affinity complex (DAC) technology, which extends its half-life and resultant therapeutic window as follows [2]:

CJC-1295 No DAC: CJC-1295 No DAC contains only straight CJC-1295 with a D-Ala at the 2-position, a Gln at the 8-position (to reduce asparagine rearrangement), an Ala at position 15 (to enhance bioactivity), and a Leu at position 27 (to prevent methionine oxidation). Without DAC technology, CJC-1295 has a half-life of around 30 minutes [1, 3].

CJC-1295 DAC: CJC-1295 with drug affinity complex (DAC) technology contains an acetate that extends the longevity of CJC-1925 by up to five to eight days and increases insulin-like growth levels for up to 29 several days following a single dose [2].

Where available online as a reference material, CJC-1295 is typically sold with the DAC additive.

Mechanism of Action

CJC-1295 works by acting on the GHRH receptor and binding to the pituitary gland receptors to stimulate the release of both GH and insulin-like growth factor 1 (IGF-1). It has been tested in animals and human test subjects.

A 2005 animal study found that CJC-1295 stimulated a “4-fold increase” in GH levels when administered to male Sprague Dawley rats. Researchers noted that when CJC-1295 was injected along with hGRF1–29 amide and CJC-1288, it caused “acute GH secretions” in all animals and produced the “largest plasma AUC of GH over a 2-h period” of all peptides [4].

Additionally, two human studies involving healthy test subjects found that CJC-1295 DAC administration produced a 2- to 10-fold increase in mean plasma GH concentrations for six days or more and a 1.5- to 3-fold increase in mean plasma IGF-1 concentration for 9-11 days [2].

Legal Status

CJC-1295 is currently classified as a research chemical with no formally recognized use. It is generally available for purchase by licensed researchers and laboratory professionals. The World Anti-Doping Agency (WADA) classifies CJC-1295 as an S2 prohibited substance [5, 6].

CJC-1295 Benefits

Research into the benefits of CJC-1295 is still pending. However, a handful of small-scale CJC-1295 studies have centered on its impact on GH secretion, the effects of cumulative doses, and the frequency of adverse events [7].

Using data from these studies, we summarize key CJC-1295 benefits in relation to sleep, muscle-building, and fat loss.

CJC-1295 and Sleep

In a 1999 study by Fehm et al, researchers investigated sleep and endocrine changes following intranasal administration of growth hormone-releasing hormone (GHRH), of which CJC-1295 is an analog. In the study, researchers administered 300mcg of GHRH or placebo to both young and elderly male subjects and recorded their sleep. The subjects receiving GHRH experienced a longer period of rapid eye movement (REM) sleep and increased slow-wave sleep (SWS), among other benefits.

Researchers surmise that CJC-1295, as a derivative of GHRH, may offer the same benefits by mimicking the dual neuronal and endocrine function of hypothalamic GHRH activity [8, 9].

CJC-1295 and Muscle Growth

As a growth hormone secretagogue, CJC-1295 is believed to increase muscle growth and strength [7, 8]. While no studies have focused specifically on CJC-1295 as a muscle-building agent, the peptide clearly increases levels of serum GH and IGF-1, both of which regulate muscle mass. GH and IGF-I have distinct effects on muscle mass regulation and help promote deep sleep, which is vitally important to all body processes including muscle formation, tissue repair, and a stronger immune system [10].

Research into the role that CJC-1295 may play in muscle building is pending.

CJC-1295 and Fat Loss

CJC-1295 promotes lipolysis with fat loss in the stomach area and has been shown to help maintain normal body composition and growth in a GHRH knockout mouse model. Notably, CJC-1295 administration was linked to the normalization of prolactin, which in animal studies has been shown to promote visceral fat accrual [7, 8, 11, 12].

Despite CJC-1295’s believed impact on weight loss and body composition, there remains a lack of data to indicate the specific dose or duration it may be administered to these ends.

CJC-1295 Side Effects

In this section, we aim to review the available research to provide readers with an overview of CJC-1295 side effects and the peptide’s overall safety profile in test subjects.

A pair of double-blind studies conducted by Teichman et al. in 2006 examined the pharmacokinetics, pharmacodynamics, and safety of CJC-1295. The studies were brief, with the first involving one of four ascending single doses over 28 days, and the second involving two or three weekly or biweekly doses over 49 days [2].

The researchers found that CJC-1295 was safe and relatively well tolerated when administered at doses of 30 or 60 μg/kg, without any notable adverse effects observed. However, the test subjects did experience the following minor side effects:

Mild injection site reactions (pain, itching, swelling)

Headaches

Diarrhea,

Hypertension

Induration

CJC-1295 administration has also been linked to mild, transitory side effects such as flushing, water retention, and insomnia [7].

Adverse effects of CJC-1295 administration may also result from improper dosage or contaminated peptides, if sourced from an untrustworthy vendor. Low-purity CJC-1295 products can contain dangerous contaminants that can lead to acute systemic toxicity. Accordingly, at Peptides.org we strongly advise that researchers procure CJC-1295 from strictly reputable sources and firmly abide by prevalent dosing guidelines, based on scientific research.

CJC-1295 Dosage Guide

CJC-1295 is typically available in the form of sterile, non-pyrogenic, white lyophilized powder for administration via subcutaneous after reconstitution with bacteriostatic water [2].

Sample CJC-1295 DAC Dosing Protocol

Drawing on past research, here is a sample CJC-1295 DAC dosing protocol that researchers may administer to observe the effects of this growth hormone secretagogue:

Dosage: 1g-2g CJC-1295 DAC per injection, depending on weight of test subjects.

Frequency: Once weekly.

Study duration: 8-12 weeks

Notes: CJC-1295 DAC is available from our preferred vendor in vials of 2g and 5g. Most studies following this protocol will thus require two CJC-1295 DAC 5g vials.

Research CJC-1295 Cycle

Researchers curious about how to cycle CJC-1295 will note that the longest studies conducted to date have lasted just 28 and 49 days. While the duration of these studies offers a rough idea of how long one CJC-1295 cycle may last, the peptide was not cycled and test subjects were only administered one course of CJC-1295 DAC [2].

Researchers planning to administer multiple courses of CJC-1295 to test subjects will note that according to Teichman et al, the “mean IGF-I levels (of the participants) remained above baseline for up to 28 days” [2]. This indicates that researchers may stop administering this peptide for at least one month following the end of the trial without affecting the IGF-I levels of the test subjects.

CJC-1295 + Ipamorelin

CJC-1295/Ipamorelin is a combination of CJC-1295 and another growth hormone secretagogue called ipamorelin. The latter is a ghrelin mimetic that works along a different pathway to CJC-1295, binding to ghrelin receptors and also stimulating the release of GH. As both CJC-1295 and ipamorelin have been linked to improved body composition, there is strong research interest in the synergistic effect of these peptides and their impact on cortisol, prolactin, and fat loss when combined.

Notably, a CJC-1295/Ipamorelin blend will typically contain CJC-1295 No DAC, and will thus need to be administered five-seven times weekly — rather than once weekly as with CJC-1295 DAC.

Where to Buy CJC-1295 Online? | 2024 Edition

Researchers interested in where to buy CJC-1295 online may be aware that this peptide is available from multiple vendors in several different forms, or blends.

However, the quality, purity, and reliability of peptides can vary significantly from one vendor to the next.

To assist researchers interested in buying CJC-1295 online, our team has reviewed a number of leading vendors and ranked them according to their pricing, delivery speed, and overall buying experience.

We recommend two vendors in particular:

CJC-1295 No DAC | Limitless Life

The team at Peptides.org has plenty of experience working with different peptide vendors. That’s why we can safely recommend Limitless Life for all research peptide needs for qualified researchers.

We like Limitless Life because of their dedication to product quality, their strict safety standards, their excellent reputation within the peptide research community, and their excellent service practices.

Below, we’ve shared a bit more about each of these distinguishing factors:

High Purity Standards: By partnering with independent laboratories, Limitless Life is able to offer extremely pure and high quality research peptides — verified by third-party testing.

Dedication to Safety: Research peptides are to be used only by qualified peptide researchers. Limitless Life takes great care to emphasize this fact on their website.

Highly Reputable: Limitless Life has earned a reputation as an honest and noteworthy company in the research peptide space, evidenced by their exceptionally low rate of credit card charge-backs and positive reviews found online.

Great Service: Limitless Life’s service team is available to answer questions promptly and helpfully seven days per week by email or phone.

What’s more, researchers can get 10% off their next order at Limitless Life simply by clicking the button below and using this code at checkout:

peptidesorg10

CJC-1295 DAC | Research Chemical

Here is why Research Chemical is considered one of the top peptides vendors in the world:

Third-Party Testing: Research Chemical has all their CJC-1295 batches purity tested with third-party labs. This ensures the highest quality peptides. Then the company posts results of the testing on their website for reference.

Multiple Payment Options: Research Chemical offers reliable credit card payments with all major brands. They also offer cryptocurrency payments for researchers.

Quick, Simple Shipping: Research Chemical offers same-day and next-day fulfillment standard. This allows researchers to get peptides in an efficient manner, thus beginning their studies with speed.

Buy CJC-1295 from our top-rated vendor...

Side Effects of CJC-1295 | Verdict

In summary, researchers interested in CJC-1295 side effects will note that the peptide enjoys a favorable safety profile, backed by nearly two decades of research.

Notably, past studies have linked CJC-1295 to mild side effects such as injection site pain, itching, swelling, headaches, and diarrhea, all of which tend to subside following discontinuation of therapy.

The peptide has been linked to key benefits in the areas of sleep and body composition, and remains on the radar of growth hormone secretagogue researchers.

Whether looking for research-grade CJC-1295 DAC, CJC-1295 No DAC, or a CJC-1295/Ipamorelin blend for the next study, researchers need look no further than our top-rated vendor.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

Optimized Dosing Formulations and Delivery Systems

Development of depot formulations capable of releasing CJC-1295 over extended periods (monthly or quarterly) could further improve convenience and compliance. Biodegradable microsphere encapsulation, subcutaneous implantable devices, and transdermal delivery systems represent potential advances in peptide delivery technology. Additionally, oral formulations utilizing permeation enhancers or nanoparticle carriers, while challenging for peptides, could revolutionize GH secretagogue therapy if bioavailability obstacles can be overcome. The integration of digital health technologies, including connected injection devices and remote monitoring platforms, may optimize protocol individualization and improve clinical outcomes. As research into peptide therapeutics advances across multiple domains, including metabolic optimization with compounds like AOD-9604 and regenerative applications, the therapeutic armamentarium for GH modulation continues to expand with increasingly sophisticated pharmacologic tools https://pubmed.ncbi.nlm.nih.gov/16352680/.
SIDE EFFECTS

Side Effects

Clinical trials reported that CJC-1295 was generally well-tolerated, with no serious adverse reactions at therapeutic doses. Common Side Effects: Injection site reactions (redness, pain, swelling) Flushing and warmth, particularly facial flushing lasting 5–10 minutes post-injection Water retention Headaches Dizziness Increased hunger Tingling or numbness in extremities Fatigue or lethargy initially Less Common Side Effects: Nausea Joint discomfort Mood changes Anxiety Flu-like symptoms Potential Concerns: The FDA has noted concerns about increased heart rate and cardiac events associated with CJC-1295. Individuals with active cancer, cardiovascular disease, or diabetes should exercise caution, as elevated GH and IGF-1 can theoretically promote cell proliferation and affect glucose metabolism.
02

Question drills

Open a question for its connected answer.

01What If Reconstituted CJC-1295 Sits at Room Temperature for 6 Hours?+

Discard it. The DAC-albumin bond forms in vivo after injection. It doesn't protect the lyophilized peptide or reconstituted solution from degradation. At room temperature (20–25°C), proteolytic enzymes and oxidative stress degrade unbound peptide at roughly 8–12% per hour. After 6 hours, potency drops below 50%, and you're injecting degraded fragments that won't bind albumin correctly. Once reconstituted with bacteriostatic water, store CJC-1295 at 2–8°C and use within 28 days. Temperature excursions above 8°C for more than 2 hours render the vial unreliable.

SOURCE / realpeptides.co ↗
02What If Injection Site Reactions (Redness, Swelling) Occur Repeatedly?+

Switch injection sites to areas with higher subcutaneous fat density (abdomen, lateral thigh) and ensure reconstituted peptide is at room temperature before injection. Cold solution causes localized vasoconstriction and inflammatory response. If reactions persist, the issue is likely bacteriostatic water sensitivity (benzyl alcohol intolerance occurs in approximately 5% of users). Reconstitute with sterile water instead, but note that shelf life drops from 28 days to 7–10 days under refrigeration.

SOURCE / realpeptides.co ↗
03What If My Target Dose Doesn't Align With Whole Tick Marks?+

If your protocol calls for 150mcg and you're working with a 1mg/mL solution (10mcg per tick), 15 ticks delivers exactly 150mcg. No rounding needed. But if you need 175mcg, standard U-100 syringes can't measure that precisely at 1mg/mL concentration (you'd be choosing between 170mcg or 180mcg). Reconstitute your next vial at 0.5mg/mL instead, where each tick equals 5mcg and 35 ticks delivers exactly 175mcg. Concentration flexibility is how you achieve dose precision without guessing between tick marks.

SOURCE / realpeptides.co ↗
04What If I Miss a Scheduled Injection by Two Days?+

Administer the missed dose as soon as you remember if fewer than three days have passed since the scheduled injection. If more than three days late, skip that dose entirely and resume your regular schedule with the next planned injection. CJC-1295's extended half-life means serum levels remain elevated for 6–8 days after administration. Missing one dose causes a dip but not a complete loss of pharmacological effect. Doubling up doses to 'catch up' pushes IGF-1 into supraphysiological territory and creates the exact metabolic disruption the twice-weekly schedule was designed to avoid.

SOURCE / realpeptides.co ↗
05What If My Reconstituted CJC-1295 Contains Mannitol?+

Verify the concentration. Mannitol is a sugar alcohol used as a stabilizer in some peptide formulations. It's approximately 50% as sweet as glucose and has a glycemic index of 0 in most individuals, meaning it doesn't spike insulin. At the trace concentrations used in peptide reconstitution (typically <1% w/v), mannitol is unlikely to break a fast. If you're using a pre-mixed solution with >5% mannitol by volume, consider switching to a bacteriostatic water-based reconstitution for stricter fasting protocols.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

What the one human CJC-1295 study found

According to PubMed, the only peer-reviewed clinical study (two randomized, placebo-controlled, double-blind ascending-dose trials over 28 and 49 days in healthy adults aged 21–61) reported dose-dependent GH increases of 2- to 10-fold and IGF-1 increases of 1.5- to 3-fold, with IGF-1 staying elevated for up to 28 days after dosing. The authors reported no serious adverse reactions and described the peptide as “relatively well tolerated” (Teichman et al., 2006, DOI). Crucially, the abstract does not publish an itemized breakdown of minor side effects or their frequencies—so any specific percentage you see quoted elsewhere is not traceable to this study. No serious adverse reactions at tested doses Over ≤7 weeks, small healthy sample only Clinical (CJC-1295, DAC) — Teichman et al., 2006 Sustained IGF-1 elevation for weeks per dose Expected pharmacodynamic effect; the basis of the long-term concern Injection-site reactions (e.g. erythema) Commonly reported for the GHRH-analog class; not itemized for CJC-1295 Clinical, related drug (tesamorelin) — Badran et al., 2026 Arthralgia, myalgia, paraesthesia (joint/muscle pain, tingling) Reported for the GHRH-analog class Insulin resistance / higher diabetes risk Not seen in the short CJC-1295 trial; documented with chronic GH/IGF-1 excess Mechanistic / observational — Thomas et al., 2021; Clayton et al., 2010 Possible cancer-promotion concern Never tested for CJC-1295; raised IGF-1 linked to slightly higher risk of some cancers Mechanistic / epidemiological — Clayton et al., 2010; Zhang et al., 2021 Unknown outcomes from the largest human trial Phase 2 (n=120, 12 weeks) terminated; no safety data published Registry — ConjuChem, NCT00267527

RESEARCH

Long-Term Considerations and Responsible Research in 2026

So, what about the long game? The most pressing questions in the research community revolve around the long-term CJC-1295 side effects. While short-term data is plentiful, longitudinal studies are still emerging. Responsible research in 2026 demands a cautious and methodical approach. The primary long-term concern remains the impact on insulin sensitivity and glucose metabolism. Any protocol that chronically elevates GH levels must account for this. Cycling—periods of administration followed by periods of cessation—is a common strategy employed to allow the body's hormonal axes to reset and maintain sensitivity. This isn't just a suggestion; it's a fundamental principle of mitigating risk. Another theoretical consideration is the downstream effect of elevated IGF-1 (Insulin-like Growth Factor 1), which is produced by the liver in response to GH. While beneficial for tissue repair and growth, chronically supra-physiological levels of IGF-1 have been a topic of scientific debate for decades regarding cellular growth signaling. This is still an area of active investigation, and it highlights why using peptides to achieve a modest, physiologically-sound increase in GH is often a more prudent research goal than aiming for extreme levels. It's about optimization, not maximization. It is imperative that you Find the Right Peptide Tools for Your Lab to ensure you can monitor these variables accurately. Navigating the world of CJC-1295 side effects requires diligence, a commitment to quality, and a deep respect for physiology. It's not about avoiding all risks—all meaningful research involves variables—but about understanding, anticipating, and managing them intelligently. The potential of GHS peptides like CJC-1295 is undeniable, but it's a potential that can only be safely and effectively explored when paired with an equally robust understanding of its safety profile. As a dedicated partner to the research community, our goal is to provide both the high-purity compounds and the transparent information necessary to push the boundaries of science forward, responsibly. It’s the only way we know how to operate.

05

Product & matchup locker

Linked catalog and comparison files.

Comparison

DAC vs Non-DAC Differences in Community Reports

GH/IGF-1 elevation Pulsatile (hours) Sustained (5-8 days) Water retention reports Less common More common Hand tingling Sleep disruption Cycle length community-typical Continuous …

Comparison

Growth Hormone Pathway Mechanisms: GHRH vs Ghrelin Receptor Targeting

CJC-1295 alternatives in 2026 best divide into two mechanistic categories: GHRH receptor agonists (which mimic the body's natural growth hormone-releasing hormone) and ghrelin rec…